$1.65 -$0.02 (0.0%)

11:07 AM EDT on 06/14/19

Oncolytics Biotech Inc Com (NASDAQ:ONCY)

CAPS Rating: 1 out of 5

A development stage company focuses on the discovery and development of oncolytic viruses for the treatment of cancers.

Current Price $1.65 Mkt Cap $46.3M
Open $1.69 P/E Ratio 0.00
Prev. Close $1.65 Div. (Yield) $0.00 (0.0%)
Daily Range $1.63 - $1.69 Volume 5,500
52-Wk Range $1.63 - $2.50 Avg. Daily Vol.

Caps

How do you think NASDAQ:ONCY will perform against the market?

Add Stock to CAPS Watchlist

All Players

76 Outperform
21 Underperform
 

All-Star Players

8 Outperform
10 Underperform
 

Wall Street

3 Outperform
1 Underperform
 

Top NASDAQ:ONCY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

DKERST (< 20)
Submitted December 14, 2012

ONCY is a long term hold of mine - 12 years.It is not over until the fat lady sings, but the fat lady is smiling today. Do your own research - the ONCY web site is very informative. Also check out the TED talk by Patrick Lee on the web. The MF… More

sleepyseth (99.71)
Submitted November 04, 2006

I hate to go so against the grain on this one and be the only bear, but its stock looks like it is heading lower to me. They just don't have anything that they can commercialize soon enough. Nothing in Phase III yet and they losing $10 million a… More

NASDAQ:ONCY VS S&P 500 (SPY)

Fools bullish on NASDAQ:ONCY are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ONCY.

Recs

0
Member Avatar PrometheusX (< 20) Submitted: 7/10/2015 6:31:00 PM : Outperform Start Price: $0.60 NASDAQ:ONCY Score: +136.30

ONCY is on the verge of having a breakthrough in treatment of a disease of civilization. Now very undervalued and with a possible future standard medication for cancer(s) in hand.

Recs

0
Member Avatar bobfarr (< 20) Submitted: 3/11/2015 8:40:24 AM : Outperform Start Price: $0.79 NASDAQ:ONCY Score: +67.66

On the cutting edge of cancer fighting viruses.

Recs

0
Member Avatar retireatwork (< 20) Submitted: 9/4/2013 4:24:24 PM : Outperform Start Price: $2.69 NASDAQ:ONCY Score: -113.44

Phase 3 results pending that will almost certainly be positive. If they avoid certain pitfalls related to execution, their product could become very widely used in oncology in a relatively short period of time.

Leaderboard

Find the members with the highest scoring picks in ONCY.

Score Leader

brwn8484

brwn8484 (< 20) Score: +1,165.90

The Score Leader is the player with the highest score across all their picks in ONCY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
BadCopNoDonuts < 20 9/24/2010 Underperform 5Y $4.75 -65.26% +154.83% +220.09 0 Comment
vbaci 29.61 9/28/2010 Underperform 5Y $4.74 -65.19% +153.43% +218.62 0 Comment
Smog79 < 20 9/28/2010 Underperform 3W $4.77 -65.41% +153.07% +218.48 0 Comment
chippybeck < 20 9/24/2010 Underperform 5Y $4.40 -62.48% +152.74% +215.23 0 Comment
longtermgrowth09 42.32 12/17/2009 Underperform 5Y $2.69 -38.66% +161.80% +200.47 0 Comment
Elwavinator 53.18 12/29/2009 Underperform 1Y $2.67 -38.20% +157.08% +195.28 0 Comment
cchigga 88.78 1/31/2012 Underperform 3W $4.61 -64.21% +119.57% +183.77 0 Comment
sleepyseth 99.71 11/6/2006 Underperform 1Y $2.38 -30.67% +124.63% +155.30 2 Comments
IntenseSpider 91.35 1/16/2007 Underperform 1Y $2.68 -38.43% +115.50% +153.93 0 Comment
mungerishx 99.73 1/9/2013 Underperform 5Y $3.60 -54.17% +98.72% +152.88 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackStifel 90.64 8/31/2012 Outperform NS $2.83 -41.70% +105.16% -146.86 0 Comment
TrackWedbush 88.21 4/13/2011 Outperform NS $5.74 -71.25% +119.47% -190.72 0 Comment
TrackJimCramer 86.18 4/7/2011 Underperform 3W $5.77 -71.40% +117.42% +188.83 0 Comment
TrackRBCCapMkts 85.57 12/22/2010 Outperform NS $6.77 -75.63% +131.01% -206.64 0 Comment

Advertisement